Zentek Ltd. is an ISO 13485-certified intellectual property development and commercialization company headquartered in Guelph, Ontario, Canada, that specializes in nanotechnology and advanced materials. Operating as a portfolio of complementary businesses, Zentek develops and commercializes three core brands: ZenGUARD™, a graphene-based antimicrobial coating technology applied to surgical masks and HVAC filters to enhance viral filtration efficiency; Triera Biosciences, a wholly owned biotech brand built on an exclusive aptamer platform for rapid therapeutic development targeting infectious diseases; and Albany Graphite, a high-purity graphite deposit in Northern Ontario positioned to supply electric vehicle battery anodes, nuclear applications, and advanced materials for North American critical-minerals supply chains. The company leverages centralized regulatory, quality, and commercialization expertise supported by an industrial-scale production facility, while pursuing multiple paths to value creation including product revenue, government contracts, strategic partnerships, and licensing arrangements. Zentek's model emphasizes owning and stewarding intellectual property across graphene-based coatings, aptamer platforms, and high-purity graphite technologies, allocating capital and resources based on risk-adjusted return potential.
Website24 Corporate Court
Guelph, ON, N1G 5G5
Canada
Detailed price information for Zentek Ltd (ZEN-X) from The Globe and Mail including charting and trades.
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Zentek Ltd. (TSX-V: ZEN; OTCQX: ZTEKF), an IP development and commercialization company, has qualified to trade on the OTCQX® Best Market. Zentek Ltd. previously traded on NASDAQ. Zentek Ltd. begins trading today on OTCQX under the symbol “ZTEKF” and, further to its press release dated August 27, 2026, will no longe
Newsfile Press Release.
TSX Venture Exchange listing, the Company's primary listing, is unaffectedGuelph, Ontario--(Newsfile Corp. - August 31, 2026) - Zentek Ltd. (TSXV: ZEN) (NASDAQ: ZTEK) ("Zentek" or the "Company") is issuing this release to correct one item in its news release of August 28, 2026 regarding the Company's OTC listing status. That release stated that the Company's common shares would begin trading on the OTC Markets at the open of trading on "Tuesday, September 2, 2026." September 2, 2026, is a...
Investors talking about ZTEK also mention
What share of all stock conversation is about ZTEK?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% 0 | 0% 0 | 0% 0 |
Of the messages about ZTEK that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 97.04% -0.92 | ||
| Bearish | — | — | — | 2.96% +0.92 |
Of the messages about ZTEK that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | — | 100% | 83.06% | ||
| Macro | — | — | 0% | 6.2% | ||
| Technical Analysis | — | — | 0% | 10.33% | ||
| Analysts | — | — | 0% | 0.41% | ||
| Controversies | — | — | 0% | 0% | ||
| Earnings | — | — | 0% | 0% |
Of the messages about ZTEK, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | — | 54.29% | 30.8% | ||
| Newcomers | — | — | 45.71% | 69.2% |